Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Vulcan Value Partners - Small Cap. This analysis is provided for institutional research purposes only and is not investment advice.
"Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA."
In their Q2 2025 investor letter, Vulcan Value Partners outlines how they converted tariff-related market volatility and macroeconomic anxiety into attractive buying opportunities. The marquee portfolio adjustments of the quarter included trading around UnitedHealth Group (UNH)—selling it early as it approached fair value, and aggressively repurchasing it following a 50%+ sell-off driven by operational headwinds and management reshuffling. Vulcan also initiated a position in clinical research giant IQVIA Holdings, citing its massive $30B backlog and cheap cash flow yield, and broadened their exposure to Ares Management. To fund these purchases, Vulcan disciplinedly exited or reduced holdings that had converged with fair value, including Carlyle Group, Heineken, and Dun & Bradstreet.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Growth Outlook
Market outlook remains above average conviction: Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Risk Appetite
Risk appetite posture is above average conviction: Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Forward Guidance
Forward guidance signal: Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Language Signal
Tone analysis indicates high conviction language: Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
Time Horizon
Investment time horizon reflects a high conviction orientation. Vulcan capitalized on Q2 tariff anxiety to execute tactical capital reallocations, notably round-tripping UnitedHealth Group and initiating a new position in IQVIA....
